ID29576A - Komposisi-komposisi mukoadesif cair oral - Google Patents

Komposisi-komposisi mukoadesif cair oral

Info

Publication number: ID29576A
Authority: ID; Indonesia
Prior art keywords: composition; safe; mixtures; effective amount; respiratory tract
Prior art date: 1998-08-24

Application number

IDW20010449A

Other languages

English (en)

Indonesian (id)

Inventor

Douglas Joseph Dobrozsi

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-24

Filing date

1999-08-24

Publication date

2001-09-06

1999-08-24 Application filed by Procter & Gamble filed Critical Procter & Gamble

2001-09-06 Publication of ID29576A publication Critical patent/ID29576A/id

Links

239000000203 mixture Substances 0.000 title abstract 8
239000007788 liquid Substances 0.000 title abstract 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
206010057190 Respiratory tract infections Diseases 0.000 abstract 1
206010046306 Upper respiratory tract infection Diseases 0.000 abstract 1
229940035676 analgesics Drugs 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
239000000730 antalgic agent Substances 0.000 abstract 1
229940125715 antihistaminic agent Drugs 0.000 abstract 1
239000000739 antihistaminic agent Substances 0.000 abstract 1
239000003434 antitussive agent Substances 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000004927 clay Substances 0.000 abstract 1
229910052570 clay Inorganic materials 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000000850 decongestant Substances 0.000 abstract 1
229940124581 decongestants Drugs 0.000 abstract 1
239000003172 expectorant agent Substances 0.000 abstract 1
230000003419 expectorant effect Effects 0.000 abstract 1
229940066493 expectorants Drugs 0.000 abstract 1
239000004083 gastrointestinal agent Substances 0.000 abstract 1
229940125695 gastrointestinal agent Drugs 0.000 abstract 1
230000007794 irritation Effects 0.000 abstract 1
210000002850 nasal mucosa Anatomy 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
210000002345 respiratory system Anatomy 0.000 abstract 1
208000020029 respiratory tract infectious disease Diseases 0.000 abstract 1
238000004062 sedimentation Methods 0.000 abstract 1
230000001953 sensory effect Effects 0.000 abstract 1
239000000377 silicon dioxide Substances 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1
239000004408 titanium dioxide Substances 0.000 abstract 1
230000001960 triggered effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Inorganic Chemistry (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Otolaryngology (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Photolithography (AREA)

IDW20010449A 1998-08-24 1999-08-24 Komposisi-komposisi mukoadesif cair oral ID29576A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9757898P	1998-08-24	1998-08-24

Publications (1)

Publication Number	Publication Date
ID29576A true ID29576A (id)	2001-09-06

Family

ID=22264129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010449A ID29576A (id)	1998-08-24	1999-08-24	Komposisi-komposisi mukoadesif cair oral

Country Status (17)

Country	Link
US (1)	US6319513B1 (tr)
EP (1)	EP1107733B1 (tr)
JP (1)	JP2002523354A (tr)
KR (1)	KR100413877B1 (tr)
CN (1)	CN1195494C (tr)
AT (1)	ATE300282T1 (tr)
AU (1)	AU761968B2 (tr)
BR (1)	BR9913178B1 (tr)
CA (1)	CA2338704C (tr)
CO (1)	CO5140082A1 (tr)
DE (1)	DE69926377T2 (tr)
HU (1)	HUP0103388A3 (tr)
ID (1)	ID29576A (tr)
NO (1)	NO20010832D0 (tr)
PE (1)	PE20000862A1 (tr)
TR (1)	TR200100628T2 (tr)
WO (1)	WO2000010529A1 (tr)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7223416B2 (en) *	1999-06-28	2007-05-29	Minu, L.L.C.	Topical composition
JP4639569B2 (ja) *	1999-07-02	2011-02-23	三菱瓦斯化学株式会社	歯牙漂白剤組成物および変色歯牙漂白方法
US20020061281A1 (en) *	1999-07-06	2002-05-23	Osbakken Robert S.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20040115133A1 (en) *	2000-05-10	2004-06-17	Wermeling Daniel P.	Intranasal opioid compositions
US20060083691A1 (en) *	2000-05-10	2006-04-20	Wermeling Daniel P	Intranasal opioid compositions, delivery devices and methods of using same
JP4822652B2 (ja) *	2000-11-22	2011-11-24	エンドファーマシューティカルズインコーポレイテッド	粘膜炎の治療
US7927600B2 (en) *	2001-03-30	2011-04-19	Emile Loria	Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
FR2822709B1 (fr) *	2001-03-30	2007-01-19	Antialis	Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
US7179476B2 (en) *	2001-08-09	2007-02-20	Sekisui Chemical Co., Ltd.	Medical composition for external use for dermatosis
WO2003017960A1 (en) *	2001-08-24	2003-03-06	Mintaco Inc.	Oral rinse for treatment or prevention of bacterial and fungal infection
US8425892B2 (en) *	2001-10-29	2013-04-23	Columbia Laboratories, Inc.	Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) *	2001-10-29	2008-07-31	Levine Howard L	Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20050003014A1 (en)	2001-12-21	2005-01-06	Ketelson Howard Allen	Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
ES2354688T3 (es) *	2002-01-15	2011-03-17	Ucb Farchim S.A.	Formulaciones para la administración oral de compuestos activos.
BG65734B1 (bg) *	2002-02-22	2009-09-30	Био Терапютикс - Еоод	Течен мукоадхезивен фармацевтичен състав
US20030166732A1 (en) *	2002-02-27	2003-09-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
EP1496867A1 (en) *	2002-04-08	2005-01-19	Lavipharm Laboratories, Inc.	Drug-complex microparticles and methods of making/using same
ES2314227T7 (es) *	2002-04-09	2012-11-19	Flamel Technologies	Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
US6919348B2 (en)	2002-05-02	2005-07-19	Edward T. Wei	Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
NZ536918A (en) *	2002-05-07	2006-09-29	Altana Pharma Ag	Combination of pantoprazole and a respiratory agent for the treatment of respiratory diseases
GB2389530B (en) *	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US7220431B2 (en) *	2002-11-27	2007-05-22	Regents Of The University Of Minnesota	Methods and compositions for applying pharmacologic agents to the ear
WO2004064828A1 (ja)	2003-01-21	2004-08-05	Senju Pharmaceutical Co., Ltd.	２−アミノ−３−(４−ブロモベンゾイル)フェニル酢酸含有水性液剤
US20050220870A1 (en) *	2003-02-20	2005-10-06	Bonnie Hepburn	Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US7459146B2 (en) *	2003-05-30	2008-12-02	3M Innovative Properties Company	Stabilized aerosol dispersions
US20040242729A1 (en) *	2003-05-30	2004-12-02	3M Innovative Properties Company	Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7109247B2 (en) *	2003-05-30	2006-09-19	3M Innovative Properties Company	Stabilized particle dispersions containing nanoparticles
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2004257864A1 (en) *	2003-07-18	2005-01-27	Santarus, Inc.	Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20050154343A1 (en) *	2004-01-14	2005-07-14	Mohinder Singh	Soft tip applicator for relieving mouth pain
US8815916B2 (en)	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050266031A1 (en) *	2004-05-25	2005-12-01	Jay Dickerson	Pharmaceutical suspension composition
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7482378B2 (en) *	2004-05-28	2009-01-27	Millenium Specialty Chemicals, Inc.	Physiological cooling compositions
WO2006020190A1 (en) *	2004-07-16	2006-02-23	Richard Plymale	Dentifrice composition
US20060046998A1 (en) *	2004-08-25	2006-03-02	Fairfield Clinical Trials, Llc	Method of treatment of gastroesophageal reflux disease and laryngopharyngeal reflux disease
PL2486942T3 (pl)	2004-11-24	2019-05-31	Meda Pharmaceuticals Inc	Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US20070020330A1 (en)	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
US8758816B2 (en)	2004-11-24	2014-06-24	Meda Pharmaceuticals Inc.	Compositions comprising azelastine and methods of use thereof
US20060210482A1 (en) *	2005-03-18	2006-09-21	John Cassara	Chemical composition and method for cold and sinus relief
US7985743B1 (en) *	2005-07-22	2011-07-26	Gene A. Tabish	Topical pain reliever and method of making the same
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007064755A2 (en) *	2005-11-30	2007-06-07	Endo Pharmaceuticals Inc.	Treatment of xerostomia with a sulfur-containing antioxidant
DOP2006000274A (es) *	2005-12-14	2007-10-15	Sanofi Aventis Us Llc	Formulación de suspensión de fexofenadina
WO2007117704A2 (en) *	2006-04-07	2007-10-18	Michalis Nicolaou	Pure isomers of tritoqualine
US8207292B2 (en) *	2007-02-12	2012-06-26	Michalis Nicolaou	Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs
US20080003280A1 (en) *	2006-06-26	2008-01-03	Levine Brian M	Combination cough treatment compounds and method of treating common coughs
CA2677076C (en) *	2007-03-02	2017-09-12	Meda Pharmaceuticals Inc.	Compositions comprising carisoprodol and methods of use thereof
PL2002733T3 (pl) *	2007-06-08	2017-06-30	The Procter And Gamble Company	Kompozycja zawierająca miód naturalny i sposoby jej sporządzania
AU2014201068B2 (en) *	2007-06-08	2016-07-07	The Procter & Gamble Company	Natural honey-containing compositions and method of preparation
ITMI20071623A1 (it) *	2007-08-03	2009-02-04	Vetagro S R L	Composizione sinergica comprendente sostanze aromatizzanti ed acidi organici, e relativo uso
DK3354276T3 (da)	2007-11-13	2020-03-30	Meritage Pharma Inc	Sammensætninger til behandlingen af gastrointestinal inflammation
WO2009132050A2 (en)	2008-04-21	2009-10-29	Otonomy, Inc.	Auris formulations for treating otic diseases and conditions
US11969501B2 (en)	2008-04-21	2024-04-30	Dompé Farmaceutici S.P.A.	Auris formulations for treating otic diseases and conditions
GB0807621D0 (en) *	2008-04-25	2008-06-04	Ineos Healthcare Ltd	Use
WO2010011605A2 (en)	2008-07-21	2010-01-28	Otonomy, Inc.	Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en)	2008-07-21	2014-07-22	Otonomy, Inc.	Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US7914828B2 (en) *	2008-10-17	2011-03-29	Levine Brian M	Combination herbal product to benefit respiratory tract
GB2477590A (en) *	2010-02-05	2011-08-10	Biocopea Ltd	A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
US11202831B2 (en)	2010-10-29	2021-12-21	Infirst Healthcare Limited	Solid solution compositions and use in cardiovascular disease
US9737500B2 (en)	2010-10-29	2017-08-22	Infirst Healthcare Limited	Compositions and methods for treating severe pain
US8895537B2 (en)	2010-10-29	2014-11-25	Infirst Healthcare Ltd.	Compositions and methods for treating cardiovascular diseases
US9504664B2 (en)	2010-10-29	2016-11-29	Infirst Healthcare Limited	Compositions and methods for treating severe pain
US10695431B2 (en)	2010-10-29	2020-06-30	Infirst Healthcare Limited	Solid solution compositions and use in cardiovascular disease
US9744132B2 (en)	2010-10-29	2017-08-29	Infirst Healthcare Limited	Solid solution compositions and use in chronic inflammation
US9271950B2 (en)	2010-10-29	2016-03-01	Infirst Healthcare Limited	Compositions for treating chronic inflammation and inflammatory diseases
US11730709B2 (en)	2010-10-29	2023-08-22	Infirst Healthcare Limited	Compositions and methods for treating severe pain
US10695432B2 (en)	2010-10-29	2020-06-30	Infirst Healthcare Limited	Solid solution compositions and use in severe pain
US11224659B2 (en)	2010-10-29	2022-01-18	Infirst Healthcare Limited	Solid solution compositions and use in severe pain
US9308213B2 (en)	2010-10-29	2016-04-12	Infirst Healthcare Limited	Solid solution compositions and use in chronic inflammation
US8361519B2 (en)	2010-11-18	2013-01-29	Aadvantics Pharmaceuticals, Inc.	Combination herbal product to benefit respiratory tract in people exposed to smoke
US20140213644A1 (en) *	2010-12-30	2014-07-31	Ziv Harish	Formulations and Methods for Prevention and Treatment of Oral Allergy Syndrome
EP2928450B1 (en) *	2012-12-06	2017-03-01	Colgate-Palmolive Company	Oral gel for sensitivity and tooth pain
EP3061501A1 (en)	2015-02-27	2016-08-31	Rottapharm Ltd.	Composition for the treatment of acne
EP3117825A1 (en)	2015-07-16	2017-01-18	Rottapharm S.p.A.	Oral formulation comprising berberine and morus alba extract
EP3328898B8 (en)	2015-07-28	2024-04-10	6452728 Canada Corp.	Trkb or trkc agonist compositions and methods for the treatment of otic conditions
AU2016381178B2 (en) *	2015-12-30	2019-06-06	Colgate-Palmolive Company	Mucin coated silica for bacterial aggregation
EP3478269A4 (en)	2016-06-29	2020-04-08	Otonomy, Inc.	OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES
US10583081B1 (en) *	2017-11-27	2020-03-10	Richard A. Myers	Apparatus and formulation for treating mouth ulcers
WO2019140012A1 (en)	2018-01-09	2019-07-18	Otonomy, Inc.	Growth factor otic formulations
WO2019154895A1 (en)	2018-02-08	2019-08-15	Strekin Ag	Gel formulation for preventing or treating hearing loss
CA3105449A1 (en) *	2018-07-02	2020-01-09	Bayer Healthcare Llc	Stable pharmaceutical formulations of oxymetazoline
LT3820439T (lt)	2018-09-11	2022-01-10	Lead Biotherapeutics Ltd.	Mukoadhezinė dispersinė nanodalelių sistema ir jos gamybos būdas
EP4233872B1 (en)	2018-10-24	2025-07-02	Ferring B.V.	Mucoadhesive pharmaceutical compositions of corticosteroids
PH12021551961A1 (en) *	2019-02-15	2022-05-23	Ferrer Medical Innovations Llc	Nasal spray compositions and related treatment methods

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3352752A (en)	1963-07-25	1967-11-14	Tintex Corp	Intestinal adsorbent compositions
JPS589083B2 (ja)	1975-05-30	1983-02-18	武田薬品工業株式会社	シヨウリユウザイノセイゾウホウ
FR2346017A1 (fr)	1975-10-23	1977-10-28	Rech Applic Scient	Composition therapeutique pour le traitement des affections du tractus gastro-intestinal
FR2502956A1 (fr)	1981-04-01	1982-10-08	Human Pharm Sa Laboratoires	Composition therapeutique utile comme topique digestif
US4427681A (en) *	1982-09-16	1984-01-24	Richardson-Vicks, Inc.	Thixotropic compositions easily convertible to pourable liquids
JPS61106509A (ja) *	1984-10-29	1986-05-24	Fujisawa Pharmaceut Co Ltd	鼻腔用医薬組成物
AU594765B2 (en)	1986-05-16	1990-03-15	Chugai Seiyaku Kabushiki Kaisha	Sucralfate preparations for applications on esophagus mucosa
US5464828A (en)	1988-03-02	1995-11-07	Chugai Pharmaceutical Co., Ltd.	Aqueous suspension of sucralfate
US5719197A (en)	1988-03-04	1998-02-17	Noven Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
US5047244A (en)	1988-06-03	1991-09-10	Watson Laboratories, Inc.	Mucoadhesive carrier for delivery of therapeutical agent
WO1991006289A1 (en)	1989-10-31	1991-05-16	Watson Laboratories, Inc.	Mucoadhesive carrier for delivery of therapeutical agent
JPH0639368B2 (ja)	1990-02-28	1994-05-25	株式会社萩原技研	シリカゲルを母体とした抗菌性組生物
GB9025710D0 (en)	1990-11-27	1991-01-09	Beecham Group Plc	Novel treatment
DE59202096D1 (de)	1991-06-07	1995-06-08	Byk Gulden Lomberg Chem Fab	Pharmazeutische klistierzubereitung.
IT1251153B (it)	1991-08-06	1995-05-04	Vectorpharma Int	Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
JPH0725769A (ja) *	1992-10-20	1995-01-27	Fuji Chem Ind Co Ltd	アロプリノール医薬用液剤ならびにその製造法
FR2710265B1 (fr)	1993-09-22	1995-10-20	Adir	Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
US5458879A (en) *	1994-03-03	1995-10-17	The Procter & Gamble Company	Oral vehicle compositions
US5554379A (en)	1994-06-20	1996-09-10	Kv Pharmaceutical Company	Long acting GI and esophageal protectant
US5670163A (en)	1994-06-20	1997-09-23	Kv Pharmaceuticals Company	Long acting GI and esophageal protectant
US5554380A (en)	1994-08-04	1996-09-10	Kv Pharmaceutical Company	Bioadhesive pharmaceutical delivery system
US5585108A (en)	1994-12-30	1996-12-17	Nanosystems L.L.C.	Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays
US5466440A (en)	1994-12-30	1995-11-14	Eastman Kodak Company	Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP3927253B2 (ja) *	1995-02-02	2007-06-06	中外製薬株式会社	スクラルファート製剤
US5580579A (en)	1995-02-15	1996-12-03	Nano Systems L.L.C.	Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
IT1275955B1 (it) *	1995-03-22	1997-10-24	Dompe Spa	Formulazioni farmaceutiche in forma di gel tissotropico
FR2739558B1 (fr)	1995-10-05	1997-11-28	Innothera Lab Sa	Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale

1999
- 1999-07-27 US US09/361,533 patent/US6319513B1/en not_active Expired - Lifetime
- 1999-08-24 BR BRPI9913178-1A patent/BR9913178B1/pt not_active IP Right Cessation
- 1999-08-24 JP JP2000565851A patent/JP2002523354A/ja active Pending
- 1999-08-24 TR TR2001/00628T patent/TR200100628T2/tr unknown
- 1999-08-24 AU AU55809/99A patent/AU761968B2/en not_active Ceased
- 1999-08-24 ID IDW20010449A patent/ID29576A/id unknown
- 1999-08-24 CA CA002338704A patent/CA2338704C/en not_active Expired - Fee Related
- 1999-08-24 KR KR10-2001-7001965A patent/KR100413877B1/ko not_active Expired - Fee Related
- 1999-08-24 DE DE69926377T patent/DE69926377T2/de not_active Expired - Lifetime
- 1999-08-24 PE PE1999000848A patent/PE20000862A1/es not_active Application Discontinuation
- 1999-08-24 CN CNB998098604A patent/CN1195494C/zh not_active Expired - Fee Related
- 1999-08-24 HU HU0103388A patent/HUP0103388A3/hu unknown
- 1999-08-24 AT AT99942429T patent/ATE300282T1/de not_active IP Right Cessation
- 1999-08-24 EP EP99942429A patent/EP1107733B1/en not_active Expired - Lifetime
- 1999-08-24 WO PCT/US1999/019202 patent/WO2000010529A1/en not_active Ceased
- 1999-08-24 CO CO99053437A patent/CO5140082A1/es unknown
2001
- 2001-02-19 NO NO20010832A patent/NO20010832D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2338704C (en)	2004-11-02
HUP0103388A2 (hu)	2002-01-28
NO20010832L (no)	2001-02-19
AU5580999A (en)	2000-03-14
AU761968B2 (en)	2003-06-12
US6319513B1 (en)	2001-11-20
EP1107733B1 (en)	2005-07-27
DE69926377D1 (de)	2005-09-01
JP2002523354A (ja)	2002-07-30
CN1195494C (zh)	2005-04-06
PE20000862A1 (es)	2000-09-13
TR200100628T2 (tr)	2001-10-22
CN1313756A (zh)	2001-09-19
BR9913178B1 (pt)	2014-11-25
KR20010072678A (ko)	2001-07-31
KR100413877B1 (ko)	2004-01-07
NO20010832D0 (no)	2001-02-19
WO2000010529A1 (en)	2000-03-02
DE69926377T2 (de)	2006-06-01
ATE300282T1 (de)	2005-08-15
CO5140082A1 (es)	2002-03-22
HUP0103388A3 (en)	2006-02-28
BR9913178A (pt)	2001-05-15
CA2338704A1 (en)	2000-03-02
EP1107733A1 (en)	2001-06-20

Publication	Publication Date	Title
DE69926377D1 (de)	2005-09-01	Orale flüssige mucoadhäsive zusammensetzungen
ATE227978T1 (de)	2002-12-15	Orale flüssige mucoadhäsive zusammensetzungen
US6165494A (en)	2000-12-26	Iodine-containing nasal moisturizing saline and mouthwash solutions
US6171611B1 (en)	2001-01-09	Iodine-containing nasal moisturizing saline and mouthwash solutions
JPH0161086B2 (tr)	1989-12-27
JPH03197430A (ja)	1991-08-28	呼吸器管感染症用スプレー剤
JP2003512325A (ja)	2003-04-02	感冒およびインフルエンザ様症状の予防並びに治療用組成物、並びにそれらの使用方法
CA2323680A1 (en)	1999-11-25	Orally disintegrable tablets
CA2321819A1 (en)	1999-09-30	Xylitol compositions for treating upper respiratory conditions
WO1994008551A3 (en)	1994-06-23	Pharmaceutical compositions and methods for treating cold symptoms
JP2004525903A5 (tr)	2005-06-23
US6929800B2 (en)	2005-08-16	Nasal passage cleaning composition
FR2712807B1 (fr)	1996-02-23	Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
DE69903651D1 (de)	2002-11-28	Orale flüssige mucoadhäsive zusammensetzungen
WO2001012128A3 (en)	2001-06-14	Antibacterial agents for the treatment of acute mucosal infections
CA2419077A1 (en)	2002-02-28	A method of treating a systemic disease
JP2001139465A (ja)	2001-05-22	咽頭粘膜用組成物
JP2007022971A (ja)	2007-02-01	経鼻投与のための組成物
JP2002145764A (ja)	2002-05-22	咽頭粘膜用組成物
BR0205625C1 (pt)	2004-10-19	Formulações nasais em gel